Rapid Micro Biosystems raised 25 million dollars in a Series C round. The company provides innovative products for faster detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. As of the investors that participated at the funding round, they include Hepalink USA, Richard K. Mellon and Sons, Kleiner Perkins Caufield & Byers,Longitude Capital, Quaker Partners, TPG Biotech and TVM Capital.
